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High elimination rates and the concern for horse welfare are important issues in
endurance riding. An improved understanding of the causes of elimination could increase
completion rates in this sport. We have identified pre-ride risk factors that allow an
assessment of potential elimination before the ride. A longitudinal cohort study was
performed among 49 healthy horses competing in the 160 km endurance ride at the 2016
World Championship of Endurance Riding in Samorin/Slovakia. Blood samples were
drawn before the ride. For statistical evaluation, horses were categorized in three groups:
finishers, lame and metabolically eliminated horses. Risk factors were calculated for
each group using multinomial logistic regression. A 1% increase in hematocrit levels was
associated with a higher OR for elimination (lameness: OR 1.26, p = 0.017; metabolic:
OR 1.34, p = 0.010). Furthermore, increased potassium values correlated negatively
with the race outcome. For a 1 mmol/l increase in potassium, the lameness OR was
4.21, p = 0.039 and metabolic OR was 1.15, p = 0.848. Eight-year-old horses had
a 100% elimination rate and survival analyses showed a significantly higher hazard for
elimination (p = 0.025). We thus conclude that age and hydration affect the outcome of
elite endurance rides. Further investigation of age as a risk factor seems to be clinically
relevant and adjustments of FEI qualification modes may be appropriate.
Keywords: endurance horse, endurance riding, World Championship, long-distance riding, infusion, risk
factor, elimination, age requirements equestrian sports
INTRODUCTION
The demanding sport of endurance riding has come under scrutiny due to questions of horse
welfare and lethal injuries in the past decade (1–5). After the disastrous World Equestrian Games
in Tryon/USA in 2018, the World Equestrian Federation (FEI) began seeking solutions to improve
horse welfare as well as the public reputation of the sport (6). Elimination rates at international
rides have remained consistently high over the last years ranging between 50 and 80% while the
speeds of the races have increased (5, 7).
Following physical exercise, specific changes in metabolic reactions occur in athletic horse
leading to several changes in the body, mainly in the circulatory, respiratory, endocrine, and
neuromuscular systems (8). Changes taking place in these systems simultaneously and in an
integrated manner are aimed at maintaining homeostasis in the body (9). However, long-term
physical exertion may result in disturbances of homeostasis, such as energy depletion and changes
in fluids, electrolytes and acid-base balance, with negative consequences for health status and
performance of horse.
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In 2009, Jami Whiting (10) published an article outlining the
special physiological characteristics of endurance horses after
elimination. The author stated that many well-trained endurance
horses have low resting hematocrit levels compared to horses
of other disciplines. Therefore, even mild hematocrit elevations
point to a severe problem (4, 11). This supports the argument
of Fielding et al. who observed only small changes in laboratory
parameters in 30 endurance horses treated for colic following a
160 km ride (12). In addition, Whiting addressed the importance
of sufficient hydration but did not further investigate water loss
and associated transportation stress (10). Despite the lack of any
scientific foundation, infusions before the race are a common
practice at international rides as riders hope to increase water
reserves in order to improve performance.
Stull and Rodiek and Padalino et al. performed research
on transportation stress and measured correlating changes in
different blood parameters (13, 14). Hematocrite (HCT) and
creatine kinase (CK) increased during transportation. At the
same time, white blood cells (WBC) showed a progressive
increase. They suspected these responses to influence the
energy availability for athletic performance following a lengthy
transportation of horses (7). Horses of the Padalino study showed
increased heart and respiratory rates, capillar refill time and
neutrophil count (10).
Other risk factors for elimination may include venue- and
environment-related aspects (15), riding strategy (16), or high
running speeds (17). Fielding et al. found breeds like Appaloosas
or Quarter horses to have a higher risk of elimination compared
to Arabians and crossbreeds. They considered this might be
due to a higher body mass index (18). In another retrospective
evaluation, it was suspected that age plays a role, but data
for 160 km rides was only available for metabolic eliminations
without any age relation (19). Among endurance riders, the view
is common that horses reach their performance peak between 11
and 13 years of age. This is supported by a study comparing the
metabolism of six-year-old horses with the metabolism of horses
with amean age of 10.2± 2.0 years (20). Among humans, a recent
study defined the best finishing age for ultra-marathon runners
between 35 and 45 years (21). Taking this into consideration—
along with high speeds as well as horse fatalities—the questions
arise whether most horses even reach their best performance age
and how long horses can actually endure in this sport (22, 23).
However, there is no valid data on how many horses fail to reach
the actively competing age of 10 or older and how long they
perform in endurance riding.
During the statistical evaluation, only few of the past
publications related to endurance riding used confounder
adjustment (17, 18). Special focus must be placed on the non-
confounder study of Trigo et al. which found HCT, plasma
protein and CK to be valid parameters for risk assessment (24).
Nevertheless, as elimination risk seems to be the result of multiple
factors, confounder adjustment is indispensable.
To our knowledge, there have not been any scholarly
publications using data of international championships, which
provide a study population of the world’s best horses. This
study addresses the questions (25) whether lameness and
metabolic status are linked by distinguishing between the two
groups compared to finishers and whether certain pre-ride
parameters point to a later elimination. It seeks to provide
a better understanding of the risk factors leading to high
elimination rates and horse fatalities. Furthermore, the study
offers recommendations for adapting FEI rules to improve overall
horse welfare.
MATERIALS AND METHODS
During the 2016 World Championship of Endurance Riding
in Samorin/Slovakia, blood samples were taken from 49
participating horses.
Participation in our study was voluntary and free of charge
for the participants. Information on the study was sent to
all starting national federations in advance via email, which
forwarded the information to their athletes. In addition, a
social media post was placed to reach as many participants
as possible. Owner-informed consent was obtained before any
animal examination and sampling. The study was performed in
accordance with EU Directive 2010/63/EU, the German Animal
Welfare Legislation and the guidelines of the Freie Universität
Berlin on the protection of animals used for scientific purposes.
Diagnostic blood collection is a common pre-ride procedure
in elite equine athletes and constitutes a standard clinical
veterinary practice. According to thementioned legal regulations,
the study cannot legally beclassified as an animal experiment.
Sampling therefore does not need any separate ethical approval,
according to German legislation, as it is a common part of
performance monitoring in endurance riding in accordance with
good veterinary practice. The blood sampling was performed by
trained veterinarians, while the owners or legal representatives
(FEI licensed and accredited trainers) were present.
The horses included in the study started for a total of 23
nations (Algeria, Australia, Bahrain, Belgium, Chile, Colombia,
Croatia, Denmark, Ecuador, Germany, United Kingdom,
Hungary, Italy, Malaysia, Netherlands, Norway, Portugal, Russia,
South Africa, Sweden, Thailand, Uruguay, USA). Relevant
information of the horses’ signalment (sex, age, breed, color) was
taken from the FEI Horse Database. According to the FEI Data,
40 horses were purebred or crossbred Arabians. Four horses were
listed as “other” and five horses were referred to as “unknown”
in the database (Table 1).
According to qualification criteria, all horses were at least 8
years old and had successfully finished at least one 160 km ∗∗∗
three star ride with a minimum average speed of 14 km/h in the
past 24 months, and two 120 km ∗∗ two start rides or higher in
their career (15, 26). All horses were up to date on influenza
vaccines as required by the FEI.
During the race, the average outside temperature was 18.9◦C
with 83% humidity. The track was mostly flat with no significant
hills. The weather was partly cloudy with repeating rain showers
and moderate wind speed.
The time between transportation, arrival at the venue and
blood sampling differed among the horses ranging from 5 days
before to the morning of the day before the start. All samples
were drawn between 9:33 a.m. and 8:38 p.m.: 32.7% between
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TABLE 1 | Distributional characteristics of the study population and summary statistics of blood values.
Finished Lameness Metabolic Missing
n 18 20 11
Sex (%)
Male
8 (44.4) 11 (55.0) 7 (63.6) 0%
Female 10 (55.6) 9 (45.0) 4 (36.4)
Age [median (range)] Years 12.0 (9.0, 16.0) 11.0 (8.0, 17.0) 11.0 (8.0, 17.0) 0%
Weight [median (range)] kg 405.0 (345.0, 440.0) 402.0 (350.0, 450.0) 408.0 (380.0, 450.0) 0%
Time between blood sampling
and race [mean (SD)]
Days 2.8 (1.1) 2.7 (0.9) 3.0 (0.8) 0%
Breed (%)
Purebred Arabians
8 (44.4) 10 (50.0) 6 (54.5) 0%
Anglo-Arabians 2 (11.1) 5 (25.0) 0 (0.0)
Shagya-Arabians 2 (11.1) 2 (10.0) 0 (0.0)
Arabian Partbreds 1 (5.6) 0 (0.0) 3 (27.3)
Other 2 (11.1) 1 (5.0) 1 (9.1)
Unknown 3 (16.7) 2 (10.0) 1 (9.1)
Infusion (%)
No
4 (26.7) 13 (65.0) 8 (72.7) 6.1%
Yes 11 (73.3) 7 (35.0) 3 (27.3)
Median (range)
RBC
106/mm3 6.9 (5.8, 8.6) 8.0 (6.2, 11.0) 7.7 (5.8, 9.4) 0%
HGB g/dl 12.1 (9.8, 14.2) 13.1 (10.8, 17.7) 12.9 (9.6, 15.7) 0%
HCT % 32.8 (26.7, 39.5) 37.8 (28.8, 50.0) 37.0 (28.2, 45.4) 0%
MCV µm3 47.0 (45.0, 52.0) 48.0 (45.0, 51.0) 48.0 (46.0, 50.0) 0%
MCH pg 16.9 (15.2, 21.1) 16.8 (15.4, 19.0) 16.7 (14.4, 19.1) 0%
MCHC g/dl 35.6 (33.9, 41.5) 35.0 (33.2, 41.3) 34.6 (30.7, 39.7) 0%
RDW % 17.0 (16.1, 18.1) 17.0 (15.8, 18.2) 17.5 (16.3, 17.8) 0%
PLT 103/mm3 173.0 (120.0, 213.0) 185.5 (130.0, 214.0) 182.0 (157.0, 217.0) 0%
MPV µm3 5.6 (5.1, 6.1) 5.6 (5.2, 6.4) 5.5 (5.0, 5.8) 0%
WBC 103/mm3 8.0 (5.6, 12.3) 9.1 (5.6, 14.3) 8.4 (5.1, 13.5) 0%
LYM 103/mm3 2.2 (1.3, 3.4) 2.5 (1.5, 5.0) 2.6 (1.5, 3.2) 0%
LYM % % 29.4 (22.1, 38.1) 27.5 (17.6, 37.4) 28.7 (20.4, 37.4) 0%
MON % % 5.3 (2.6, 7.8) 5.6 (2.3, 8.7) 5.8 (1.9, 8.7) 0%
GRA 103/mm3 5.0 (3.3, 8.5) 6.2 (3.8, 9.0) 5.8 (3.3, 9.2) 0%
GRA % % 66.2 (54.2, 74.4) 67.4 (56.2, 77.7) 65.7 (56.8, 77.5) 0%
EOS % % 1.5 (0.5, 3.8) 1.5 (0.7, 8.0) 1.7 (0.7, 4.6) 0%
Potassium mmol/l 3.2 (1.8, 4.8) 3.6 (2.5, 4.4) 3.4 (2.0, 4.0) 0%
Sodium mmol/l 135.0 (131.0, 138.0) 135.0 (131.0, 138.0) 134.0 (130.0, 138.0) 2%
Total calcium mmol/l 3.1 (2.9, 3.3) 3.1 (2.9, 3.3) 3.1 (3.0, 3.3) 0%
CK U/l 244.5 (164.0, 420.0) 314.5 (214.0, 1217.0) 250.0 (184.0, 432.0) 0%
WBC, white blood cells; LYM, absolute lymphocytes; LYM%, relative lymphocytes, MON, absolute monocytes; MON%, relative monocytes (MON%); EOS%, relative eosinophils; GRA,
absolute granulocytes; GRA%, relative granulocytes; RBC, red blood cells; HBG, hemoglobin; MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration;
MCH, mean corpuscular hemoglobin; RDW, red cell distribution width; PLT, absolute thrombocytes; MPV, mean platelet volume; CK, creatine kinase.
9 a.m. and 2 p.m. and 67.3% between 3 p.m. and 9 p.m. Before
the sampling, each horse underwent a general examination in
accordance with the endurance rules, excluding gait. Heartrate,
skin turgor, mucosal membrane, back and girth, gut sounds and
muscle turgor were recorded. Horses were not fastened. Weight
was measured using standardized weight measuring tape.
The horses’ presenters (rider, owner, groom, or team vet) were
asked to report any treatment the horse had undergone within the
last 7 days, especially fluid substitution directly prior to traveling
or directly after arriving at the venue. For three horses this was
unknown, so these animals were excluded from the statistical
evaluation of the “infusion” variable.
Overall, 9.8ml jugular venous blood was collected using the
Braun vacutainer R© system (Melsungen, Germany) with a 20-
gauge-needle. Each horse was sampled with one 4ml 13× 75mm
PET hemogard K2 EDTA 1.8 mg/ml tube and one 4ml 13 ×
75mm PET hemogard lithium heparin 17 IU/ml.
Two laboratory technicians conducted the blinded testing at
the temporary laboratory set up at the venue. EDTA blood was
used for hematology evaluation in the Scil VET ABC (Viernheim,
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Germany): white blood cells (WBC), absolute lymphocytes
(LYM), relative lymphocytes (LYM%), absolute monocytes
(MON), relative monocytes (MON%), relative eosinophils
(EOS%), absolute granulocytes (GRA), relative granulocytes
(GRA%), red blood cells (RBC), hemoglobin (HGB), mean
corpuscular volume (MCV), mean corpuscular hemoglobin
concentration (MCHC), mean corpuscular hemoglobin (MCH),
red cell distribution width (RDW), absolute thrombocytes
(PLT) and mean platelet volume (MPV) were measured. A
lithium-heparin tube was used for the commercially available
biochemistry panel in the VetScanVS2 (Abaxis, USA) with an
Equine Profile rotor with full blood to measure sodium (Na+),
potassium (K+), creatin kinase (CK) and calcium (Ca+2).
Chloride was not included in the rotor and therefore could not be
measured. According to requirements of Abaxis, Lithium heparin
was spinned off at 4,000 g/4min if hematocrit was>50% and then
plasma was used for the Equine Profile Rotor. If hematocrit was
<50% full blood was used.
Results were transferred directly from the laboratorymachines
to the Scil VIP Manager Software (Viernheim, Germany).
Elimination of 8-year-old horses was compared to the rest
of the field using a Kaplan-Meier-Curve. As survival time the
vetgate of elimination was used. Finishing horses were censored
at vetgate 5. A p-value for the difference in survival between 8
and ≥9-year-old horses was computed using a log-rank test. The
results data is available in Supplementary Table 1.
Horses were divided into three groups: finishing (18
horses), lame (20 horses), and metabolically (11 horses)
eliminated athletes. All blood values were checked for normality
using histograms and prior knowledge about distribution.
Only CK had to be log-transformed to achieve a normal
distribution. For statistical evaluation, we used multinomial
logistic regression with finishing as reference vs. lameness or
metabolic elimination (R package mgcv version 1.8-31) (27).
We calculated univariable odds ratios with 95% confidence
intervals. All possible confounders were identified using DAG’s
software DAGitty (28) and checked for association with
exposure and outcome. Multivariable analyses were adjusted
for the identified confounders of age, sex and weight. For
all confounders, crude odds ratios are reported. Additionally,
crude and adjusted odds ratios were calculated for infusion
status. All p-values ≤0.05 were considered significant. All
statistical analyses were performed using R Version 4.0.0
(R Foundation Vienna).
Breed was not considered to be a confounder because the
variable “breed” only had a weak association with the race result
(Cramer’s V = 0.353) and most horses were either purebred or
crossbred Arabians.
RESULTS
One hundred and thirty-one riders started in the race, 47 riders
completed it. This equals to a completion rate of 35.87%, which is
higher than the finisher rates of the world championships in 2014
(22.89%) and 2012 (35.37%) (29). No data for 2018 is available
due to the ride being canceled.
TABLE 2 | Dropout percentage by age.
Age in years All competing horses Study population
Dropout (%) n Dropout (%) n
8 100 6 100 4
9 62.5 24 75 8
10 42.9 21 42.9 7
11 70 20 71.4 7
12 61.9 21 57.1 7
13 57.1 14 33.3 6
14 83.3 12 50 2
15 66.7 6 66.7 3
16 66.7 3 50 2
17 75 4 100 3
FIGURE 1 | Survival Curve of the Elimination of 8-year-old horses vs.
≥9-year-old horses. Kaplan-Meier-Curve of the elimination of 8-year-old
horses (red, dashed) and ≥9-year-old horses (blue, solid). The gate of
elimination was used as the time point. Finishing horses were censored at gate
5 and are visually shown as a extra time point “Finisher.” P-value was
calculated using a log-rank test. 8-year-old horses had a significantly higher
hazard for elimination (p = 0.025) compared to ≥9-year-old horses.
Regarding the total race 21 horses (16.03%) were eliminated
for metabolic issues, four riders retired (3.05%), three riders
failed to complete a loop (2.29%), of which one suffered a
catastrophic injury, and 56 horses (42.74%) were eliminated
for lameness.
None of the six 8-year-old horses of the 132 overall ride
participants finished the race. The highest completion rate could
be found among the 10-year-old horses (21 horses), where 57.1%
finished the race. A similar percentage could be observed in the
study population (Table 2). Survival analysis showed that 8-year-
old horses had a significantly higher hazard for elimination (p =
0.025, see Figure 1) compared to ≥9-year-old horses.
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Forty-nine horses were included in the study. None of the
horses showed abnormalities in the pre-sampling examination
and all passed the pre-ride inspection. Of the 49 horses
(23 mares/26 geldings), 11 horses (22.45%) were eliminated
for metabolic issues, 20 horses (40.82%) were eliminated for
lameness issues and 18 horses (36.73%) finished the race. The
median age of the horses sampled was 12.0 (9.0, 16.0) for
finishers, 11.0 (8.0, 17.0) for lame and 11.0 (8.0, 17.0) for
metabolic horses.
The median weight of the horses was 405.0 (345.0, 440.0) kg
for finishers, 402.0 (350.0, 450.0) kg for lame and 408.0 (380.0,
450.0) kg for metabolic horses.
All variables presented in the following section were adjusted
for age, sex and weight. Only small changes in blood values
were observed. None of the findings showed any indication of
a pathological process.
The reference value for all following parameters is the median
of finisher horses and can be seen in Figure 2.
As Figure 2 shows, for every 1% increase in hematocrit levels,
horses had a 1.3-times higher chance of lameness and a 1.3-
times higher chance of metabolic elimination. An increase of
one unit of red blood cells (106/mm3) resulted in a 3.0-times
higher chance of lameness and a 3.7-times higher chance of
metabolic elimination. Horses with an increased hemoglobin
(g/dl) before the race had a 1.7-times higher chance of lameness
and a 1.8-times higher chance for metabolic elimination per one
unit increase. A higher amount of PLT increased the chance of
elimination for lameness by 1.4 and metabolic reasons by 1.5 for
every increase by 103/mm3.
Horses showing a significant elevation of CK before the
competition had a 15.7-times higher chance of elimination
for lameness for every doubling of the CK value. CK did
not contribute to metabolic elimination. Pre-race elevation of
potassium increased the chance of lameness elimination to 4.2-
times per one unit compared to finishing horses but did not affect
the chance of metabolic elimination.
Other measures of blood cell count or electrolytes only had
a minor impact on the ride outcome (see Figure 2). Unadjusted
OR are reported in Supplementary Table 2.
Eleven out of 18 horses of the finisher group (73.3%), seven
out of 20 horses of the lameness group (35.0%) and 3 out of 11
horses of the metabolic group (27.3%) had received an infusion
(intravenous administration of fluids) prior to or directly after
transport. Horses that had received an infusion prior to or
directly after transport had 82% reduced odds of lameness (OR
= 0.181; 95% CI 0.038–0.851; P = 0.031) and 88% reduced odds
(OR = 0.116; 95% CI 0.017–0.763; P = 0.025) of metabolic
elimination after adjusting for age, sex and weight. Horses that
had received fluid support traveled between 4 and 10 h without
a recreational break. Horses traveling longer spent an overnight
break midway so individual traveling times did not exceed 10 h
according to the presenter. All horses with fluid substitution
had received 5–10 L of 0.9% sodium chloride on the day of
transportation. None of the horses receiving infusions after
transport were sampled on the day of arrival.
As a sensitivity analysis, we adjusted the blood values using
multinomial logistic regression for the infusion, which only
resulted in a small decrease of the effect on the overall blood
values. This is an indicator that pre- or post-transport infusion
only explains a small portion of the observed value changes.
DISCUSSION
We analyzed race results, blood parameters and pre-race
treatments of 49 horses competing in the World Championship
of Endurance Riding. To our knowledge, this was the first
time horses of an international endurance championship
were examined.
We hypothesized that the change of different blood values
prior to the ride would affect the chance of elimination.
Differences among blood samples of the finishers, lame and
metabolic eliminated horses in electrolytes and red blood cell
count were expected. The study showed that reduced values
of red blood cell count with lowered potassium had a positive
impact on the outcome of the competition. Also, older horses
with fluid substitution pre- or post-transportation had a higher
possibility of completing the race.
The fact that sampling only took place before one race,
multiple parameters were evaluated and there were only 49
participating horses must be kept in mind as limitations of
this observational study. In addition, sampling times among
the analyzed horses were not standardized as riders were not
willing to change their regular routine due to the ride being a
championship. Further information on the “infusion” variable—
especially precise application times and individual transportation
duration—were not provided by the presenters. A recent long-
term evaluation showed a consistently decreasing starting age
among horses since 2004 (7). The study indicated that the most
reliable age for finishing is between 10 and 15, with chances of
finishing increasing with every additional year of age. As heart
rate variability also improves with age, it does not seem surprising
that age may affect the chance of finishing (30). Numbers of
starting and therefore included horses for analyzing the effect
of age could not be influenced by the authors and were the
highest in 10 years, except for Aachen 2006 (159 starting horses)
and only minimally higher numbers in Euston Park 2012 (147
starting horses).
The tendency of having horses start at a younger age
must be viewed very critically. Due to current FEI endurance
regulations and international qualification modes, horses can
start as early as 5 years of age and may enter international
rides only 1 year later. Young horses are, therefore, at risk
of not reaching the best performance age due to severe
health issues resulting from early heavy and fast training.
In the observed race, younger horses were more at risk
of metabolic elimination than older horses (compared to
lameness) and it is particularly notable that none of the 8-
year-old horses finished the race. In addition, younger horses
were also eliminated earlier from the race than older horses.
Taking these findings into consideration, we recommend to
reconsider the starting age for CEI ∗∗∗ 160 km races and the
minimumperiod between first qualification ride and first possible
international start.
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FIGURE 2 | Blood value odds ratios for lameness or metabolic elimination. The figure shows odds ratios for elimination due to lameness or metabolic reasons
depending on blood values based on 49 horses. Odds ratio are calculated for changes by one unit of change. OR above 1 mean that the odds of elimination
increases with blood values higher than the finisher group. For OR below 1 the odds for elimination is higher for blood values lower than the finisher group. OR are
shown as point estimates (circle or square) with 95% confidence intervals as error bars. Orange shows OR for lameness and green show OR for metabolic elimination.
P-values below 0.05 can be considered significant. WBC, white blood cells; LYM, absolute lymphocytes; LYM%, relative lymphocytes; MON, absolute monocytes;
MON%, relative monocytes (MON%); EOS%, relative eosinophils; GRA, absolute granulocytes; GRA%, relative granulocytes; RBC, red blood cells; HBG, hemoglobin;
MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration; MCH, mean corpuscular hemoglobin; RDW, red cell distribution width; PLT,
absolute thrombocytes; MPV, mean platelet volume; CK, creatine kinase.
Further investigation of age influencing finisher rates,
especially in combination with speed, is needed. Due to the
ride being a championship, the atmosphere has been more
competitive and therefore may have had encouraged riders to
push the horses further than during normal rides (15). To make
more general statements, measurements and analysis should
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be repeated under different conditions. The sampling included
only one ride with moderate temperatures. The number of
participating horses for the parameter age was evaluated for the
49 study horses and compared to the over-all number of 131
starting horses. Since these numbers were similar, we assume our
results to be transferable. A retrospective evaluation of age and
point of elimination of older championships could give useful
information. Further investigation of the risk factor age of the
authors is in progress.
Regarding the connection between weight and race results,
Fielding et al. have already stipulated that the risk of elimination
increases among breeds associated with a higher body mass
index (18). According to our results, the weight of the
horse may influence the chance of metabolic elimination.
Although medians of weight in our study were similar among
the tested groups, the interval for lame horses was slightly
wider than for finisher horses. The weight interval for horses
eliminated for metabolic reasons was notably higher and wider
(380.0, 450.0 kg) and could not be explained by the difference
in breeds.
Previous studies show a wide individual range for CK in
finisher horses and CK alone does not serve as an indicator
for successful race completion (31, 32). Therefore isolated
CK values must always be evaluated in combination with
clinical appearance and other laboratory parameters, such as
myeloperoxidase or elastase or in combination withHCT as listed
below (33). Elevated pre-competition CK values in our study
population point to a significantly increased risk of elimination
due to lameness. This might be caused by muscular damage
(34) resulting from over-training, transportation stress (35),
insufficient recovery breaks (36) before the ride or reduced
renal elimination (37) due to dehydration (38). All these points
influence potential muscle performance and, as a result, may lead
to lameness elimination in the race (39).
The study data showed no major differences within the red
blood cells and related parameters of lame and metabolic horses.
However, these were significantly elevated compared to finishing
horses. Values of RBC, PLT, HGB, and HCT in healthy horses
can be affected by numerous factors, such as dilution, medical
and supplemental support (e.g., iron), management, time of
sampling, exercise prior to the ride, or individual horse traits.
However, these factors have been consistent among all competing
horses and are, therefore, not expected to play a role. Feeding
has been identified as increasing HCT due to the loss of fluid
in saliva and the gastrointestinal tract (40). According to the
presenters, all of the horses had been offered hay continuously
since arriving at the venue, which may have had a slight impact
on our numbers.
Higher values of HGB and RBC in horses can also be caused by
altitude training or the administration of erythropoietin during
training (41, 42). Generally, elevated numbers of HGB and RBC
are considered to have a positive impact on performance (41, 42).
In contrast, low values for HCT, RBC, PLT, and HBG seemed
to influence the outcome positively in our study. As altitude
training has been reported to be a common measure in human
athletes to increase HGB and RBC and to enhance performance
(43–45), this would confirm doubts in human medicine that
altitude training in elite compared to non-elite athletes turned out
not to bring any further improvement (46, 47). An explanation
for this quite surprising result might be that increased values
of HGB, HCT, and RBC could be an indicator for a reduced
hydration status. The hydration status being a possible cause
of many problems leading to higher elimination rates is
supported by Whiting (10). Insufficient hydration can be
caused by stress during transportation (14), a lack of pre-
or post-transportation fluid substitution, insufficient food and
water intake, mismanagement in training, or uncomfortable
accommodation. With regard to clinical relevance, the authors
see pre-ride testing of hematology and CK as a useful tool to
identify potential risk factors of elimination.
The study measured total calcium as this was included in the
Equine Profile Rotor of Abaxis. For clinical use ionized calcium
is preferred.
Chloride was not measured due to the use of commercially
available testing kits on the venue. As chloride is one of
the main electrolytes altered in endurance horses the missing
measurement of chloride and the measurement of total calcium
reflect limitations in the study design.
In order to compare hematology parameters, a standardized
testing period before the ride is necessary. Sampling times could
not be standardized due to the design of the study. As the FEI
rules do not allow any needle insertion into the skin from 2 h
before the pre-ride inspection until the end of the race, sampling
of all horses 48 h before the race until 2 h before the pre-ride
inspection would have been a proper time frame in order to
standardize the procedure. However, as mentioned before, this
was not possible as horses underwent individual routines the
handlers did not want to adjust to a study protocol. HCT values
of >40% and CK values of 470 U/l or higher may point to
uncompensated problems. Trigo et al. use HCT > 52% and CK
>12.6 ui/l as cut-off values, which seem too high according to
our findings (24). A possible explanation for the significantly
different figures may be the fact that all horses in this study
count among the world’s elite compared to more amateur horses
in Trigos et al.’s work. Moreover, Trigo et al.’s study included
different ride lengths in the evaluation (15∗ one star rides,
9∗∗ two star rides and 12∗∗∗ three star rides on international
FEI CEI level). Taking these numbers into consideration, the
authors recommendwithdrawing affected horses from the race. A
potential treatment of these animals to improve blood values does
not seem compatible with horse welfare, as the time frame would
be too short for secure and sufficient recovery. However, more
testing with greater numbers of horses is necessary to validate
exact figures, possibly distinguishing between ride lengths as well
as amateur vs. elite horses.
This study cannot determine whether finisher horses had
been hydrated sufficiently or whether eliminated horses had been
hydrated insufficiently prior to the race.
Our results show that low values of potassium were associated
with a higher chance of finishing. According to our study, horses
with higher potassium levels are more likely to be eliminated due
to lameness. This confirms the findings of Fraipoint (48). The
underlying clinical mechanism likely is an increased potassium
excretion in the animal’s urine, as McKeever et al. found in
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1987. Only 5 weeks of training induced hypervolemia, reduced
potassium plasma levels as well as osmotic renal clearance (49).
The potassium excretion is the result of an increased renal
as well as fecal elimination, naturally associated with increased
water loss (50). A decrease in hydration then leads to a reduced
blood flow, followed by reduced muscle perfusion resulting in
lameness and increased CK values. It is also possible that pre-
ride increased plasma values of potassium prevent further muscle
cell leakage of potassium leading to muscle fatigue (51, 52).
Another result of increased potassium might be neuromuscular
hyperexcitability, which could also result in elimination (53).
Since potassium plasma levels and HCT can be modified by
training, both values in our study represent real alterations (49).
As all nations in our study used 0.9% sodium chloride for fluid
substitution, lower values of potassium in finishers may also be
the result of forced hydration due to the Na+-K+-ATPase.
However, our sensitivity analysis showed that the changes
in blood values cannot solely be explained by pre- and
post-transportation fluid substitution. It must be taken into
consideration that this investigation might not be related to
the common practice of infusion 1 day before the race. Time
between sampling and last fluid administration differed and
6.1% of the study population could not give any information
on fluid substitution. As feeding strategies were not assessed, it
is also possible electrolyte values were influenced by nutritional
supplementation (50).
Stress of transportation has been addressed as a major issue
in other studies before and is highly likely to affect performance
(54). According to Padalino et al. Arabians and crossbred
Arabians are more susceptible to transportation stress (54).
When arriving at the venue, horses’ body reserves have been
strained and time for compensation before the competition is
short. Barton et al. found lactate to be lower in horses that had
spent more time at the event venue compared to those staying
there for shorter periods (55).
This raises the question of whether pre- or post-transport fluid
substitution is an indicator for more professional management
of a horse’s metabolism, and whether it might be a proxy
for advanced feeding, medical supplementation, transportation
strategies and further optimization. However, we assume fluid
substitution surrounding the transport including all related
practices may have a positive effect on finishing.
CONCLUSION
Our study for the first time assessed differences between finishers
and eliminated endurance horses in a world championship.
It indicates that more research on transportation stress
of endurance horses, the questionable procedure of forced
hydration and its effect on race outcome is necessary. An
observational study fully capturing pre-race management and
transport factors that could explain our observed blood value
changes is needed.
We also recommend a randomized controlled trial for the
effect of pre-race infusion on finishing as this is a common
procedure in top-level endurance horses.
Retrospective evaluations of weight, especially age combined
with speed and the duration of horses’ endurance careers may
lead to valuable insights in order to improve horse welfare and
training in the future.
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